• Back To Listing

Completion of placing and buyback of shares in respect of the disposal of the majority of controlling shareholding in Allscripts-Misys Healthcare Solutions, Inc.

Misys plc is pleased to announce that it has today successfully completed its placing by way of underwritten public offering of 27,000,000 shares of common stock in Allscripts held by two wholly-owned subsidiaries of Misys plc (the "Selling Shareholders"). The shares were sold at a public offering price per share of US$17.05 (before underwriting discounts and other fees and expenses) resulting in aggregate sale proceeds of approximately US$442 million (after underwriting discounts but before other fees and expenses).

Upon the completion of the placing, Allscripts today bought back from Misys an aggregate of 24,442,083 shares of Allscripts common stock at a price per share of US$23.62 resulting in aggregate sale proceeds of approximately US$577.4 million.
 

Accordingly Misys has today received a total of approximately US$1,019.4 million in cash as a result of the placing and the buy back.
 

The underwriters were granted an option to require the Selling Shareholders to sell up to a further 4,050,000 shares of Allscripts common stock. This over allotment option was also exercised today for settlement approximately 3 business days after exercise and will result in further sale proceeds of approximately US$67 million (after underwriting discounts but before other fees and expenses).
 

Misys also intends to exercise its option to require Allscripts to buy back from the Selling Shareholders an additional 5,313,807 shares of Allscripts common stock at a price per share of US$19.12 upon completion of the Allscripts/Eclipsys merger, resulting in additional aggregate sale proceeds of approximately US$101.6 million.
 

The placing, the buy back and the additional buy back form part of the transaction whereby Misys is disposing of the majority of its controlling stake in Allscripts. Following completion of the Allscripts/Eclipsys merger and the additional buy back, Misys will have received a total of approximately US$ 1,188 million in sale proceeds for this disposal (before fees and expenses).
 

Following this disposal, Misys will hold an aggregate of 19,005,620 shares representing 10.2 per cent of the outstanding shares of Allscripts common stock.

ENDS